Brokerages Set Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) PT at $514.91
Shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Get Free Report) have been given a consensus recommendation of “Moderate Buy” by the twenty-nine ratings firms that are covering the company, MarketBeat reports. Thirteen equities research analysts have rated the stock with a hold rating, fifteen have assigned a buy rating and one has given a strong […]
Shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Get Free Report) have been given a consensus recommendation of “Moderate Buy” by the twenty-nine ratings firms that are covering the company, MarketBeat reports. Thirteen equities research analysts have rated the stock with a hold rating, fifteen have assigned a buy rating and one has given a strong […]
